Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs

Abstract Background In the era of second-generation ALK tyrosine kinase inhibitors (ALK-TKIs), there was a paucity of data regarding the progression patterns, resistant mechanisms, and subsequent therapeutic approaches for ALK-positive (ALK+) non-small cell lung cancer (NSCLC). Methods Patients with...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lige Wu, Zihua Zou, Yan Li, Xuezhi Hao, Jianming Ying, Junling Li, Puyuan Xing
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-06-01
Edice:	Journal of Translational Medicine
Témata:	ALK NSCLC Real-world study Resistance
On-line přístup:	https://doi.org/10.1186/s12967-024-05388-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!